Number of people with diabetes who are long-term users of glucose regulating medication (A10B) with concomitant use of ≥ 1 prescription angiotensin converting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB).

Number of people who are long-term users of glucose regulating medication (A10B) with concomitant use of ≥ 1 prescription angiotensin converting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB)

Number of people who are long-term users of glucose regulating medication (A10B) with concomitant use of ≥ 1 prescription antihypertensives (ATC-C02) or diuretics (ATC C03) or beta-blockers (ATC C07) or calcium channel blockers (C08) or angiotensin converting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB). Number of people who are long-term users of glucose regulating medication (A10B) are defined as individuals who use >270 Defined Daily Doses (DDD) of A10B per year. If prescribing database does not report DDD, derive indicator using >270 days of A10B per year

OECD

www.oecd.org/els/health-systems/hcqi-primary-care.htm

www.oecd.org/els/health-systems/Definitions-of-Health-Care-Quality-Outcomes.pdf